FIELD: medicine.
SUBSTANCE: invention concerns dermatology and represents an external composition which is intended for treatment of atopic dermatitis and containing adenosyl-cobalamin in a liposome as an active ingredient and a pharmaceutically acceptable liposome carrier or an excipient.
EFFECT: invention provides improved skin penetration, intensified therapeutic action, and smaller side actions and more stable.
13 cl, 18 ex, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| EXTERNAL THERAPEUTIC AGENT FOR PATIENTS SUFFERING ATOPIC DERMATITIS | 2012 |
|
RU2496476C1 |
| CREAM FOR TREATMENT OF INFLAMMATORY DISEASES OF THE SKIN | 2022 |
|
RU2792058C1 |
| COMPOSITION COMPRISING PROBIOTIC BACTERIA OR COMPONENTS THEREOF, AND METHOD FOR USE THEREOF IN TREATING IMMUNE SKIN DISEASES | 2017 |
|
RU2699540C2 |
| COMPOSITION OF DERMAL MEDICATION FOR EXTERNAL APPLICATION | 2010 |
|
RU2572694C2 |
| COMPOSITION BASED ON ZINC PYRITHIONE AND METHOD OF OBTAINING IT | 2009 |
|
RU2414884C1 |
| COENZYME Q-CONTAINING CUTANEOUS COMPOSITIONS AS ACTIVE COMPONENT | 2001 |
|
RU2283098C2 |
| COMPOSITION FOR SKIN CARE POSSESSING ANTI-ITCHING EFFECT | 2005 |
|
RU2288734C1 |
| PROANTHOCYANIDIN-CONTAINING TOPICAL PHARMACEUTICAL COMPOSITIONS FOR TREATMENT OF DERMATITIS | 2003 |
|
RU2320362C2 |
| TRAILING MAHONIA EXTRACT, PRODUCTION METHOD AND PHARMACEUTICAL COMPOSITION CONTAINING EXTRACT | 2004 |
|
RU2388482C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATING SKIN DISEASES | 2013 |
|
RU2553600C2 |
